TFF Pharmaceuticals, Inc.
NASDAQ: TFFP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Harlan F. Weisman
- Employees
- 19
- Headquarters
- Austin, United States
- IPO year
- 2019
- Market cap
- $288.8K
- Website
- https://www.tffpharma.com
Loading TFFP…
Loading profile data…Frequently asked questions about TFFP
What does TFF Pharmaceuticals, Inc. (TFFP) do?
Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals, Inc., leverages its proprietary Thin Film Freezing (TFF) technology platform for the advancement and commercialization of therapeutic products across the United States and Australia. A primary emphasis is placed on creating inhaled dry powder formulations to address va...
Where does TFFP trade?
TFF Pharmaceuticals, Inc. (TFFP) trades on the NASDAQ Global Market.
What sector is TFFP in?
TFF Pharmaceuticals, Inc. (TFFP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of TFF Pharmaceuticals, Inc.?
Harlan F. Weisman is the chief executive officer of TFF Pharmaceuticals, Inc. (TFFP).
Where is TFF Pharmaceuticals, Inc. headquartered?
TFF Pharmaceuticals, Inc. is headquartered in United States.
Does TFFP pay a dividend?
TFF Pharmaceuticals, Inc. (TFFP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TFFP go public?
TFF Pharmaceuticals, Inc. (TFFP) completed its initial public offering in 2019.